FutureMeds @home will be exhibiting at the 2026 Rare Trials Summit in Boston.
Published
Signal category
Presence & Recognition
Quote
“FutureMeds @home will be exhibiting at the 2026 Rare Trials Summit in Boston.”
— FutureMeds team
Company
FutureMeds
Finding answers faster, together
- Industry
- Research Services
- Location
- Liverpool, GB
- Company size
- 397 employees
FutureMeds is an independent, fully-owned European Site Network and DCT service provider dedicated to running patient-centric clinical trials and delivering quality data for the world’s leading Sponsors & CROs. With 30 strategically located sites across 7 countries, over 220 experienced investigators, and more than 1400 homecare providers, FutureMeds offers site and DCT solutions across most therapeutic areas and provides reliability, efficiency and accuracy to help clients accelerate patient access to new treatments. To learn more about how FutureMeds can support your trial, reach out to our team or visit futuremeds.com LinkedIn Privacy Policy: https://www.futuremeds.com/linkedin-privacy-policy
Founded 2019